This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Patients with pathologically confirmed pancreatic cancer (primary)
Patients who underwent Radical resection of pancreatic cancer（Pancreaticoduodenectomy or Distal pancreatectomy）
The postoperative survival time was at least 6 weeks
No surgery was performed, or only palliative surgery/ biopsy was performed
Patients who underwent emergency hemodialysis or plasma exchange after surgery
History of gout or long-term urate-lowering therapy, such as allopurinol
Patients are missing follow-up data
Radical pancreatic cancer resection patients
Cohort
Retrospective
serum uric acid test
Diagnostic testDetect the serum uric acid in blood sample
Overall survival
Overall survival was defined as the time from diagnosis to death.
Recurrence-free survival
Recurrence-free survival is the length of time from either the date of diagnosis or the start of therapy for a disease to the date of the first loco-regional or systemic recurrence.
Cost of hospitalization
The cost of the first hospitalization from admission to discharge.
Length of hospital stay
The first day of hospitalization for the first admission to the last day of discharge.
Pancreatic fistula
Whether or not pancreatic-intestinal anastomotic leakage occurred at the time of the first hospitalization.
Click on the lead sponsor to view all of their trials.
